Codex DNA Inc.

NASDAQ: DNAY · Real-Time Price · USD
1.30
0.10 (8.33%)
At close: Jan 04, 2023, 6:00 AM

Codex DNA Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
27.43M 11.04M
Cost of Revenue
11.84M 6.74M
Gross Profit
15.6M 4.3M
Operating Income
-49.71M -40.31M
Interest Income
n/a n/a
Pretax Income
-48.45M -38.94M
Net Income
-48.42M -38.96M
Selling & General & Admin
38.62M 25.13M
Research & Development
23.46M 14.55M
Other Expenses
n/a n/a
Operating Expenses
62.08M 39.67M
Interest Expense
-1.22M -1.37M
Selling & Marketing Expenses
16.49M 10.9M
Cost & Expenses
73.92M 46.42M
Income Tax Expense
-24K 14K
Shares Outstanding (Basic)
29.46M 21.32M
Shares Outstanding (Diluted)
29.46M 21.32M
EPS (Basic)
-1.64 -1.83
EPS (Diluted)
-1.64 -1.83
EBITDA
-46.48M -39.41M
EBIT
-46.44M -40.31M
Depreciation & Amortization
3.23M 908K